268 related articles for article (PubMed ID: 21051559)
21. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
Balog B; Tőke J; Róna K; Szücs N; Igaz P; Pusztai P; Sármán B; Gláz E; Kiss R; Patócs A; Rácz K; Tóth M
Orv Hetil; 2015 Apr; 156(16):626-35. PubMed ID: 25864138
[TBL] [Abstract][Full Text] [Related]
23. Significance of Alpha-inhibin Expression in Pheochromocytomas and Paragangliomas.
Mete O; Pakbaz S; Lerario AM; Giordano TJ; Asa SL
Am J Surg Pathol; 2021 Sep; 45(9):1264-1273. PubMed ID: 33826547
[TBL] [Abstract][Full Text] [Related]
24. Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion.
Geroula A; Deutschbein T; Langton K; Masjkur J; Pamporaki C; Peitzsch M; Fliedner S; Timmers HJLM; Bornstein SR; Beuschlein F; Stell A; Januszewicz A; Prejbisz A; Fassnacht M; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2019 Oct; 181(4):409-420. PubMed ID: 31370000
[TBL] [Abstract][Full Text] [Related]
25. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
[TBL] [Abstract][Full Text] [Related]
26. Urinary catecholamines and the diagnosis of phaeochromocytoma in Auckland.
McNeil AR; Woollard GA
N Z Med J; 1997 Sep; 110(1051):331-3. PubMed ID: 9323371
[TBL] [Abstract][Full Text] [Related]
27. A comprehensive characterisation of phaeochromocytoma and paraganglioma tumours through histone protein profiling, DNA methylation and transcriptomic analysis genome wide.
Chatzikyriakou P; Brempou D; Quinn M; Fishbein L; Noberini R; Anastopoulos IN; Tufton N; Lim ES; Obholzer R; Hubbard JG; Moonim M; Bonaldi T; Nathanson KL; Izatt L; Oakey RJ
Clin Epigenetics; 2023 Dec; 15(1):196. PubMed ID: 38124114
[TBL] [Abstract][Full Text] [Related]
28. Localizing value of catecholamine profile in patients with adrenal or ectopic pheochromocytoma.
Azizi M; Day M; Plouin PF
Am J Hypertens; 1994 Jan; 7(1):110-1. PubMed ID: 8136104
[No Abstract] [Full Text] [Related]
29. Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status.
Eisenhofer G; Lenders JW; Siegert G; Bornstein SR; Friberg P; Milosevic D; Mannelli M; Linehan WM; Adams K; Timmers HJ; Pacak K
Eur J Cancer; 2012 Jul; 48(11):1739-49. PubMed ID: 22036874
[TBL] [Abstract][Full Text] [Related]
30. Biochemical diagnosis of phaeochromocytoma: two instructive case reports.
Stewart MF; Reed P; Weinkove C; Moriarty KJ; Ralston AJ
J Clin Pathol; 1993 Mar; 46(3):280-2. PubMed ID: 8463426
[TBL] [Abstract][Full Text] [Related]
31. Does iodine-131 meta-iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma?
Taïeb D; Sebag F; Hubbard JG; Mundler O; Henry JF; Conte-Devolx B
Clin Endocrinol (Oxf); 2004 Jul; 61(1):102-8. PubMed ID: 15212651
[TBL] [Abstract][Full Text] [Related]
32. Levodopa therapy in Parkinson's disease: influence on liquid chromatographic tandem mass spectrometric-based measurements of plasma and urinary normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Brown S; Peitzsch M; Pelzel D; Lattke P; Glöckner S; Stell A; Prejbisz A; Fassnacht M; Beuschlein F; Januszewicz A; Siegert G; Reichmann H
Ann Clin Biochem; 2014 Jan; 51(Pt 1):38-46. PubMed ID: 23873873
[TBL] [Abstract][Full Text] [Related]
33. Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas.
Bouloux PM; Grossman A; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):319-25. PubMed ID: 3708878
[TBL] [Abstract][Full Text] [Related]
34. [Catecholamine-producing tumors].
Chávez Lara B
Arch Inst Cardiol Mex; 1991; 61(6):553-9. PubMed ID: 1793308
[TBL] [Abstract][Full Text] [Related]
35. Plasma and 24 h-urinary catecholamine concentrations in normal and patient populations.
Ross GA; Newbould EC; Thomas J; Bouloux PM; Besser GM; Perrett D; Grossman A
Ann Clin Biochem; 1993 Jan; 30 ( Pt 1)():38-44. PubMed ID: 8434866
[TBL] [Abstract][Full Text] [Related]
36. Phaeochromocytoma: a ten-year survey.
Loh KC; Shlossberg AH; Abbott EC; Salisbury SR; Tan MH
QJM; 1997 Jan; 90(1):51-60. PubMed ID: 9093589
[TBL] [Abstract][Full Text] [Related]
37. Biochemical Diagnosis of Chromaffin Cell Tumors in Patients at High and Low Risk of Disease: Plasma versus Urinary Free or Deconjugated
Eisenhofer G; Prejbisz A; Peitzsch M; Pamporaki C; Masjkur J; Rogowski-Lehmann N; Langton K; Tsourdi E; Pęczkowska M; Fliedner S; Deutschbein T; Megerle F; Timmers HJLM; Sinnott R; Beuschlein F; Fassnacht M; Januszewicz A; Lenders JWM
Clin Chem; 2018 Nov; 64(11):1646-1656. PubMed ID: 30097498
[TBL] [Abstract][Full Text] [Related]
38. Clinical and biochemical features of sporadic and hereditary phaeochromocytomas: an analysis of 41 cases investigated in a single endocrine centre.
Patócs A; Karádi E; Tóth M; Varga I; Szücs N; Balogh K; Majnik J; Gláz E; Rácz K
Eur J Cancer Prev; 2004 Oct; 13(5):403-9. PubMed ID: 15452453
[TBL] [Abstract][Full Text] [Related]
39. Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
März J; Kurlbaum M; Roche-Lancaster O; Deutschbein T; Peitzsch M; Prehn C; Weismann D; Robledo M; Adamski J; Fassnacht M; Kunz M; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():722656. PubMed ID: 34557163
[TBL] [Abstract][Full Text] [Related]
40. Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma.
Hickman PE; Leong M; Chang J; Wilson SR; McWhinney B
Pathology; 2009 Feb; 41(2):173-7. PubMed ID: 19152190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
